![]() |
|
|
Vol. 284, Issue 1, 202-207, 1998
Leiden/Amsterdam Center for Drug Research, Division of
Pharmacology, 2300 RA Leiden, The Netherlands (B.T., V.M.M.H., M.D.),
and
Stanford University School of Medicine, Department of Anesthesia,
Stanford, California (J.W.M.)
In the present investigation, the extent of arteriovenous concentration
differences of midazolam in rats was quantified, and the consequences
of these differences on the pharmacodynamic estimates were determined.
The arterial concentration-effect relationships were analyzed by a
traditional-effect compartment model that characterizes the delay
between blood and the effect site with the rate constant keo. Venous concentration-effect relationships
where analyzed according to the traditional model and an
extended-effect compartment model that, by incorporating an additional
rate constant kvo, can characterize the delay
between the arterial and venous sampling site. Significant hysteresis
was observed in the arterial but not the venous concentration-effect
relationships. Rate constants for keo,
kvo and terminal half-life were (mean ± S.E.M.) 0.32 ± 0.062, 0.093 ± 0.013 and 0.0217 ± 0.0008 min
1, respectively, indicating the existence of
significant arteriovenous concentration differences. Pharmacodynamic
estimates as determined on basis of the arterial concentrations and the
traditional-effect compartment model were EC50 = 104 ± 1 ng/ml, Emax = 151 ± 4 µV/sec and
= 0.83 ± 0.06. Analysis of the venous concentration-effect relationships on basis of the traditional- or extended-effect compartment model led to similar pharmacodynamic estimates, indicating that the observed arteriovenous concentration differences did not
result in biased pharmacodynamic estimates. This is due to the fact
that the effect relevant elimination rate constant of midazolam is
relatively small compared with its keo. The
observed results are consistent with earlier reports based on computer simulations.
This article has been cited by other articles:
![]() |
A. Yassen, E. Olofsen, A. Dahan, and M. Danhof Pharmacokinetic-Pharmacodynamic Modeling of the Antinociceptive Effect of Buprenorphine and Fentanyl in Rats: Role of Receptor Equilibration Kinetics J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1136 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Upton, G. L. Ludbrook, A. M. Martinez, C. Grant, and R. W. Milne Cerebral and lung kinetics of morphine in conscious sheep after short intravenous infusions Br. J. Anaesth., June 1, 2003; 90(6): 750 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ibrahim, A. Karim, J. Feldman, and E. Kharasch The Influence of Parecoxib, a Parenteral Cyclooxygenase-2 Specific Inhibitor, on the Pharmacokinetics and Clinical Effects of Midazolam Anesth. Analg., September 1, 2002; 95(3): 667 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. de Roode, J. M. A. van Gerven, R. C. Schoemaker, F. H. M. Engbers, W. Olieman, J. R. Kroon, A. F. Cohen, and J. G. Bovill A Comparison of the Effects of Propofol and Midazolam on Memory During Two Levels of Sedation by Using Target-Controlled Infusion Anesth. Analg., November 1, 2000; 91(5): 1056 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Christiaens, C. Janssenswillen, C. Verborgh, I. Moerman, P. Devroey, A. Van Steirteghem, and F. Camu Propofol concentrations in follicular fluid during general anaesthesia for transvaginal oocyte retrieval Hum. Reprod., February 1, 1999; 14(2): 345 - 348. [Abstract] [Full Text] [PDF] |
||||